Latest filing published 05 Aug 2019 for Prometic Life Sciences Inc..
Bruce Pritchard is a declared insider of Prometic Life Sciences Inc., with filings sourced from SEDI. Over a trading history stretching from 13 October 2006 to 5 July 2019, the count stands at 50 filings.
In open-market terms, that means 3 purchases worth €85k on one side and 14 sales worth €682k on the other. Taken together, the sales exceed the purchases by €597k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 11 option exercises.
A typical purchase (the median) is worth €23k.
The record was last updated on 5 August 2019 with a transaction in Prometic Life Sciences Inc. The most recent open-market purchase was published on 22 August 2017, 3,351 days ago. The median gap between a trade and its publication by SEDI is 5 days. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 50 declarations